Abstract:Background: Current studies on CD62P have focused mainly on cardiovascular diseases, while only few studies have evaluated the effects of CD62P on the development of sepsis and the association between endothelial cell injury with inflammation and coagulation. This study attended to explore the association between endothelial cell injury with inflammation and coagulation by evaluating the expression of soluble CD62P (s-CD62P) in plasma and its mechanism in patients with sepsis, thus to provide the evidence of effective treatment of sepsis with anti-adhesion therapy targeted CD62P. Methods: A total of 70 critically ill patients with systemic inflammatory response syndrome (SIRS) admitted to intensive care unit (ICU) between September 2009 and February 2010 were enrolled for a prospective and control study. According to the diagnostic criteria of sepsis/SIRS, the patients were divided into two groups: a sepsis group (n=38) and a SIRS group (n=32). Another 20 healthy volunteers served as a control group. Patients in the sepsis group and SIRS group were matched by clinical signs of high blood pressure, diabetes and its complications. The demographics of the patients including age, sex, body mass index (BMI), smoking and alcohol addict were compared among the groups. Six mL peripheral blood samples were collected within 24-hour admission in ICU for enzymelinked immunosorbent assay (ELISA) to detect the plasma levels of s-CD62P, TNF-α, and hs-CRP. And variables of coagulation function such as platelet (PLT), prothrombin (PT), activated partial thromboplastin time (APTT), D-dimer and antithrombin-III (AT-III) were analyzed during 24 hours after admission to ICU. Meanwhile sequential organ failure assessment (SOFA) score of critically ill patients was evaluated. Data were expressed as mean±standard deviation and were statistically analyzed by using SPSS 17.0 statistical software. The differences in plasma levels of s-CD62P of patients in each group were analyzed by ANOVA and the Kruskal-Wallis test. The relations between s-CD62P and inflammatory cytokines as well as with coagulation were determined by Pearson's product moment correlation coefficient analysis. Changes were considered as statistically significant if P value was less than 0.05. Results: Compared with the control group and SIRS group, the sepsis group demonstrated significantly higher levels of s-CD62P, TNF-α and highly sensitive C-reactive protein (hs-CRP) (P<0.05). The plasma levels of D-dimer, PT, and APTT in the sepsis and SIRS groups were significantly higher than those in the control group, while the platelet count and the activity of AT-III were obviously lower (P<0.05). In the sepsis group, the plasma levels of hs-CRP and TNF-α were positively correlated with PT, APTT, and D-dimer, and negatively correlated with AT-III and PLT (P<0.05). The plasma levels of s-CD62P were significantly correlated with the plasma levels of TNF-α, hs-CRP, D-dimer, PT, and APTT, whereas they were correlated negatively well with PLT and AT-III (P<0.05). Conclusions: The concentration of plasma s-CD62P is elevated as a early biomarker in patients with sepsis, and it serves as one of the pathogenic factors responsible for endothelial cell damage. Coagulation and mediators of inflammation promote each other, aggravating the severity of sepsis. Plasma s-CD62P may be an important factor for the development of coagulation and inflammatory reaction.

The expression of uPA and uPAR in patients with systemic inflammatory response syndrome

Dynamic changes in plasma levels of urokinase type plasminogen activator and urokinase type plasminogen activator receptor in patients with systemic inflammatory response syndrome

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome

Coagulation Dysfunctions in Patients with Systemic Inflammatory Response Syndrome

Regular Changes of Serum D-Dimer Level and Its Related Factors in ICU Patients with SIRS

Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome

[Expression of Urokinase-Type Plasminogen Activator and Its Receptor in Plasma of Patients with Cerebral Infarction].

Relationship of vascular endothelial dysfunction to the patients with systemic inflammatory response syndrome and multiple organ dysfunction syndrome

Clinic Values of Detecting Blood Coagulate Function and Systemic Inflammatory Response Syndrom in Acute Pancreatitis Patients

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

Serum Plasminogen Activator Urokinase Receptor Predicts Elevated Risk of Acute Respiratory Distress Syndrome in Patients with Sepsis and is Positively Associated with Disease Severity, Inflammation and Mortality

Clinical significance of plasma level of vasoactive substances in systemic inflammatory response syndrome

Relationship Between Plasma suPAR Level and Acute Coronary Syndrome With its Influencing Factors

Clinical Value of Serum Hypersensitive C-reactive Protein, Transferrin, Complement C3 and C4 in Children with Systemic Inflammatory Response Syndrome

Explore the mechanism of systemic inflammatory response syndrome induced MODS in acute infarction

Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis

Correlation Of Plasma Supar Expression With Disease Risk And Severity As Well As Prognosis Of Sepsis-Induced Acute Respiratory Distress Syndrome

Serum acute phase reactants sCRP, SAA, IL-6 in acute coronary syndrome and its clinical significance

Dynamic Change of Blood Coagulation in SIRS Patients

Endothelial cell injury with inflammatory cytokine and coagulation in patients with sepsis